This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Brand Names
- Adenovirus Type 4 and Type 7 Vaccine, Live
- Generic Name
- Adenovirus type 7 vaccine live
- DrugBank Accession Number
- DB14685
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Inactivated - Synonyms
- Human adenovirus B serotype 7 strain 55142 antigen
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbacavir The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Abacavir. Abatacept The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Abatacept. Acyclovir The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Acyclovir. Adalimumab The risk or severity of adverse effects can be increased when Adalimumab is combined with Adenovirus type 7 vaccine live. Adefovir dipivoxil The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Adefovir dipivoxil. Aldesleukin The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Aldesleukin. Alefacept The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Alefacept. Alemtuzumab The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Alemtuzumab. Altretamine The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Altretamine. Amantadine The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Amantadine. 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Adenovirus Type 4 and Type 7 Vaccine, Live Adenovirus type 7 vaccine live (32000 [TCID_50]/1) + Human adenovirus e serotype 4 strain cl-68578 antigen (32000 [TCID_50]/1) Kit; Tablet, coated Oral Teva Women's Health, Inc. 2011-09-16 Not applicable US 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- TM54L796SN
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Kit; tablet, coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at September 11, 2018 21:33 / Updated at June 12, 2020 16:53